Sleep Apnea and Gout: A Newly Understood Connection

Recent research highlights a significant link between obstructive sleep apnea (OSA) and an increased risk of developing gout, the most prevalent form of arthritis. This emerging understanding underscores the intricate connections within our body’s systems and the far-reaching impact of conditions often considered distinct. For individuals diagnosed with OSA, or those experiencing its symptoms, this study provides yet another compelling reason to seek prompt medical evaluation and treatment. The findings not only solidify a suspected correlation but also suggest potential new avenues for managing and preventing gout in a specific patient population.

iStock (2)

A pivotal study, published online on August 30, 2018, in the journal Arthritis and Rheumatology, revealed that individuals afflicted with OSA face a substantially higher likelihood of developing gout, a painful inflammatory arthritis characterized by swollen, stiff, and tender joints. The research meticulously tracked participants over time, observing that 4.9 percent of those diagnosed with OSA eventually developed gout, in stark contrast to just 2.6 percent of individuals without OSA. This data translates to a greater than 50 percent increased risk, particularly evident within the initial one to two years following an OSA diagnosis. This finding signals an important consideration for clinical practice.

It is important to note that while there are three main types of sleep apnea—obstructive, central, and complex—this particular study focused exclusively on obstructive sleep apnea. OSA is the most common form, occurring when the muscles in the throat relax excessively during sleep, causing the airway to narrow or close entirely. Central sleep apnea, on the other hand, involves the brain failing to send proper signals to the muscles controlling breathing, while complex sleep apnea is a combination of the other two. By concentrating on OSA, the researchers aimed to isolate the specific impact of this prevalent condition on gout development.

The increased risk of gout, while initially pronounced, does not diminish quickly. Dr. Milica Blagojevic-Bucknall, a senior lecturer in statistics at the Arthritis Research UK Primary Care Centre at Keele University in the United Kingdom, emphasized that this elevated risk persists well beyond the immediate period following an OSA diagnosis. Her analysis indicated that individuals with sleep apnea retained an approximately 45 percent higher risk of developing gout compared to those without the condition, even over a more extended timeframe. This sustained risk highlights the importance of ongoing vigilance and long-term management strategies for individuals with OSA to mitigate potential gout development.

Intriguingly, the study’s findings also presented an unexpected observation: the risk of gout was found to be higher in individuals with a normal body mass index (BMI) who also had sleep apnea. This seemingly counterintuitive result can be largely attributed to the severity of the obstructive sleep apnea itself and the effectiveness of its treatment. Patients with more moderate or severe OSA are typically prescribed continuous positive airway pressure (CPAP) therapy. These individuals are often more obese, while those with milder OSA may initially be advised on lifestyle interventions such as weight loss or oral appliances. Given that CPAP therapy is highly effective in reversing the pathology of OSA, including improvements in associated conditions like hypertension, its early and consistent use in more severe cases may potentially influence long-term gout risk.

Dr. Blagojevic-Bucknall further elaborated that the sustained risk observed in individuals with lower BMI might be because CPAP therapy, when effectively utilized, can significantly reverse the underlying physiological issues associated with OSA, including improvements in conditions like hypertension. This suggests that while lower BMI might seem protective, the presence of OSA, particularly when untreated or mild enough not to warrant immediate CPAP, still carries a significant risk. She underscored that irrespective of a person’s BMI, awareness of the potential for gout is critical for anyone experiencing sleep apnea, emphasizing the need for further research to solidify the relationship between CPAP use and a reduction in gout risk.

Expanding on the discussion of body measurements, it is also pertinent to consider that neck and waist circumference can sometimes serve as more accurate indicators of sleep apnea risk than BMI alone. These measurements offer a more granular insight into body fat distribution, particularly visceral obesity, which is closely linked to the development of OSA and various other health conditions. Visceral fat, which accumulates around internal organs, has been shown to contribute to airway narrowing and inflammation, thereby increasing the likelihood of sleep apnea. Therefore, healthcare professionals may consider these specific measurements when assessing an individual’s risk profile for OSA and its related complications.

The most plausible scientific explanation for the connection between obstructive sleep apnea and gout lies in the phenomenon of intermittent hypoxia. During episodes of sleep apnea, individuals experience repeated drops in blood oxygen levels (hypoxia), followed by periods of re-oxygenation. This fluctuating oxygen environment places significant stress on the body’s metabolic processes. It is believed that this intermittent hypoxia triggers an overproduction of uric acid within the body. Uric acid is a natural waste product, but when its levels become excessively high, it can crystallize and deposit in joints, leading to the excruciating pain and inflammation characteristic of gout attacks.

This proposed mechanism raises a critical question for both clinicians and researchers: could the effective correction of hypoxia through sleep apnea treatments, such as CPAP therapy, lead to a reduction in serum uric acid levels? Theoretically, if CPAP successfully alleviates the oxygen deprivation that drives uric acid overproduction, it could potentially serve a dual purpose: not only reducing the risk of new gout incidents but also potentially aiding in the management of existing gout. Therefore, addressing sleep apnea promptly is not merely about improving sleep quality; it is a holistic approach to mitigating broader health risks.

Individuals should be aware of the common symptoms of obstructive sleep apnea to seek timely medical attention. This condition occurs when the tongue or other soft tissues in the throat collapse, blocking the airway during sleep. Key indicators include intense fatigue and difficulty concentrating throughout the day, often despite what feels like a full night's rest. Loud snoring, a hallmark sign, is frequently reported by sleeping partners. Short periods of breathing cessation during sleep, followed by sudden waking accompanied by gasping or choking, are also critical red flags. Other symptoms may include waking with a dry mouth, a sore throat, or a headache, along with less obvious signs such as depression, irritability, high blood pressure, nighttime sweats, and a decreased sex drive. Since many of these symptoms manifest during sleep, it is often helpful to consult a sleeping partner for observations.

Diagnosing obstructive sleep apnea typically begins with a thorough medical evaluation by a healthcare professional. After ruling out any physical blockages in the ear, nose, or throat, which could contribute to breathing difficulties, the physician will likely recommend an overnight sleep study. This comprehensive test can be conducted either in a specialized sleep clinic or, in some cases, at home. During the study, various physiological parameters are meticulously monitored, including heart activity, lung function, brain waves, airflow through the respiratory system, body movements, and crucial blood oxygen levels. The data collected from a sleep study provides an accurate picture of sleep patterns and any breathing abnormalities, enabling a definitive diagnosis of OSA.

Parallel to understanding sleep apnea, recognizing the signs and symptoms of gout is equally crucial. Gout is characterized by sudden, severe attacks of pain, most commonly affecting the big toe, though it can impact any joint. These attacks are typically intense and abrupt, often striking in the middle of the night. After the initial excruciating peak, the pain tends to subside but persists at a lower, nagging level for days or even weeks. During a flare-up, the affected joint appears visibly swollen and red, and it becomes extremely tender to the slightest touch. Over time, repeated gout attacks can lead to increasing limitation in the movement of the affected joint, causing chronic discomfort and potential joint damage.

For a precise diagnosis of gout, a physician may recommend a series of specific tests designed to identify the presence of urate crystals or high uric acid levels. A common diagnostic procedure is a joint fluid test, where a small sample of fluid is extracted from the affected joint and examined under a microscope for the characteristic needle-shaped urate crystals. Imaging techniques such as dual-energy computed tomography (CT) scans or ultrasound may also be employed to visualize urate deposits within the joints or surrounding tissues. Additionally, a blood test is routinely ordered to measure the levels of uric acid and creatinine in the blood, providing insight into the body's uric acid production and kidney function. X-rays may also be used, primarily to rule out other potential causes of joint inflammation and to assess any long-term joint damage.

Given the potential for both obstructive sleep apnea and gout to lead to significant health complications if left unaddressed, seeking professional medical assistance is paramount. Untreated sleep apnea can contribute to various cardiovascular issues, fatigue-related accidents, and, as research now confirms, an increased risk of gout. Similarly, unmanaged gout can lead to chronic joint pain, irreversible joint damage, and even kidney stones. Early diagnosis and appropriate treatment for both conditions are essential steps toward mitigating these risks, improving overall quality of life, and preventing further deterioration of health.

Original article: https://www.everydayhealth.com/gout/gout-risk-higher-with-obstructive-sleep-apnea/